Join the club for FREE to access the whole archive and other member benefits.

inSphero

3D Cell-Based Solutions for Drug Discovery.

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of transcriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors or primary cells to mimic structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

Visit website: https://insphero.com/

 InSphero

 insphero

 InSphero

Details last updated 09-Aug-2020

inSphero News

Becoming Cyborg: 10 Amazing MedTech Inventions

Labiotech - 15-Dec-2015

Some of the best developments from 2015: Google contact lens with wireless chip and glucose sens...

Read more...
Topics mentioned on this page:
Stem Cells, Laboratory Automation